Skip to main content
. 2014 Jun 17;9(6):e100119. doi: 10.1371/journal.pone.0100119

Table 2. Statistical analysis of all cases for Enneking functional score.

Summary statistic Univariate Multivariate: initial modelP<0.05 in univariate Multivariate: final modelP<0.05 in step-down method
Factor Category N Average SD 95% CI P value 95% CI P value 95% CI P value
Gender Male 30 22.1 4.5 [0.031*] [0.292]
Female 16 19.2 3.8 (−5.616, −0.276) 0.031* (−3.674, 1.140) 0.292
Chemotherapy No 26 22.3 5.0 [0.036*] [0.108]
Yes 20 19.6 3.1 (−5.330, −0.185) 0.036* (−4.101, 0.425) 0.108
Resection range Total scapulectomy 25 19.0 3.7 [0.003**] [0.118] [0.006**]
Acromion preserved 7 22.6 3.2 (0.245, 6.898) 0.036* (0.074, 6.279) 0.045* (0.503, 6.593) 0.024*
Glenoid preserved 3 21.3 3.1 (−2.420, 7.087) 0.327 (−2.236, 6.409) 0.334 (−1.799, 6.881) 0.243
Both of acromion and glenoid preserved 9 24.7 4.7 (2.643, 8.691) <0.001*** (0.517, 6.970) 0.024* (2.615, 8.137) <0.001***
Resection of lower half 2 26.0 5.7 (1.283, 12.717) 0.018* (−4.650, 9.931) 0.467 (−5.511, 8.696) 0.652
Resected nerve No 34 22.0 4.3 [0.017*] [0.246]
Axillary 12 18.5 4.1 (−6.390, −0.669) 0.017* (−4.061, 1.076) 0.246
Follow-up term (mons) <20 13 17.8 3.0 [0.002**] [0.039*] [0.005**]
≥20<70 17 22.8 4.8 (2.038, 7.799) 0.001** (0.357, 5.804) 0.028* (1.182, 6.362) 0.005**
≥70 15 21.5 3.3 (0.658, 6.583) 0.018* (1.016, 6.463) 0.009** (1.451, 6.807) 0.003**
Unknown 1 30.0 (4.040, 20.268) 0.004** (−2.096, 19.365) 0.111 (2.085, 22.174) 0.019*

Multivariate analysis was performed using seventeen factors of the patient’s background to determine which influence Enneking’s functional score or active range of motion for all cases and for total scapulectomy cases, separately. The amount of remaining bone influenced the Enneking functional score, which means that preserving the glenoid or the acromion lead to better function compared to total scapulectomy. However, there was no significant evidence that reconstruction improved total functional outcome.